Montara Therapeutics awarded $3.3 million non-dilutive MJFF grant to develop BrainOnly™ Parkinson's therapy targeting LRRK2, a genetically validated target with major drug development challenges. New ...

May, Scotland will host its inaugural Patient Access Seminar, a landmark event exploring how patients in Scotland gain access to innovative medicines in Scotland.

Dunfermline remain in talks with Neil Lennon over him taking charge of the team next season, Press Sport understands.